Head of Scientific Office
Austrian Medicines and Medical Devices Agency, Austria
Andrea Laslop joined the Austrian Medicines and Medical Devices Agency, a business unit of the Austrian Agency for Health and Food Safety, upon its foundation on January 1st, 2006. She is the head of the Scientific Office, which constitutes the link to the European Medicines Agency (EMA) with a focus on the different types of centralised European procedures during drug development, marketing authorisation and life-cycle management. Since 2003 she is a member of the EMA Scientific Advice Working Party and from 2007 until the end of 2022 she served as delegate in the Committee for Medicinal Products for Human Use at the EMA.
Prior to this Andrea Laslop worked as professor of pharmacology and toxicology at the Medical University of Innsbruck, Austria, where she had earned her degree as medical doctor with subsequent specialisation in pharmacology and toxicology.
Disclosure information not submitted.
Drug Development in EU: Regulatory Standards, Support and New Approaches
Tuesday, October 3, 2023
8:30 AM – 4:00 PM EDT
Health Authority Forum: European Medicines Agency (EMA)
Wednesday, October 4, 2023
8:00 AM – 9:15 AM EDT
Wednesday, October 4, 2023
2:00 PM – 3:00 PM EDT
Ensuring Patient Registries Support Regulatory Decision-Making
Wednesday, October 4, 2023
3:30 PM – 4:30 PM EDT